California

The Department of Health Care Services posted the following alerts and weekly notices on the Medi-Cal Rx Web Portal. Please note the reinstatement resources and information below. 

• Evusheld® No Longer Authorized to Prevent COVID-19 (February 14) 
• NCPDP Reject Code 83 – Duplicate Paid/Captured Claim (February 14) 
• Reminder: Establishing Medical Necessity (February 14)
• Mpox Treatment Drug, Tecovirimat (TPOXX® or ST-246), as a Medi-Cal Pharmacy Benefit (February 13) 
• Boostrix™ Claims System Issue (February 13) 
• Medi-Cal Rx Weekly Wrap-up for February 3-9 (February 10) 
• Reinstatement Spotlight (February 10) 

Also in California, Medi-Cal posted the following:  

• Medi-Cal Update – Pharmacy – February 2023 – Bulletin 1033 (February 16) 
• Medi-Cal Update – Durable Medical Equipment and Medical Supplies – February 2023 – Bulletin 569 (February 16) 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.